Literature DB >> 1842428

Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes.

M Carneiro1, A J Romanha, E Chiari.   

Abstract

The development in C3H mice of thirteen strains of Trypanosoma cruzi belonging to different zymodemes and schizodemes was studied. Host mortality, virulence, histiotropism, parasitemia and polymorphism of the parasites were recorded. The strains were grouped into: a) high virulence--causing 100% mortality and characterized by predominance of very broad trypomastigotes in the bloodstream at the end of infection; b) medium virulence--causing no mortality and with a predominance of broad trypomastigotes; c) low virulence--causing no mortality with blood forms not described due to the very low parasitemia. During 18 months maintenance the parasitemia curves were kept constant for all strains except one. A direct correlation between either zymodeme or schizodeme and experimental biological properties of T. cruzi strains was not found. However, the parasitemia was subpatent and patent for strains from zymodeme C and the others respectively. Furthermore the high virulence seems to be related to one of two schizodemes found within zymodeme B strains. All strains presenting patent parasitemia independent of shizodeme and zymodeme showed a myotropism towards heart and skeletal muscle with variable inflammatory intensity. The present study confirmed the heterogeneity found by isoenzyme and k-DNA patterns among the strains of T. cruzi isolated from chagasic patients in Bambuí, Minas Gerais State, Brasil.

Entities:  

Mesh:

Year:  1991        PMID: 1842428     DOI: 10.1590/s0074-02761991000400002

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  12 in total

1.  Transcriptomic signatures of alterations in a myoblast cell line infected with four distinct strains of Trypanosoma cruzi.

Authors:  Daniel Adesse; Dumitru A Iacobas; Sanda Iacobas; Luciana R Garzoni; Maria de Nazareth Meirelles; Herbert B Tanowitz; David C Spray
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

2.  Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts.

Authors:  Marta Bértoli; Miriam Hitomi Andó; Max Jean De Ornelas Toledo; Silvana Marques De Araújo; Mônica Lúcia Gomes
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

3.  Random amplified polymorphic DNA profiles of Trypanosoma cruzi isolates from chagasic patients with different clinical forms.

Authors:  D A D'Avila; E D Gontijo; E Lages-Silva; W S F Meira; E Chiari; L M C Galvão
Journal:  Parasitol Res       Date:  2006-01-14       Impact factor: 2.289

4.  Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis.

Authors:  E Chiari; A B Oliveira; M A Prado; R J Alves; L M Galvão; F G Araujo
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

5.  Influence of the long-term Trypanosoma cruzi infection in vertebrate host on the genetic and biological diversity of the parasite.

Authors:  V M Veloso; A J Romanha; M Lana; S M F Murta; C M Carneiro; C F Alves; E C Borges; W L Tafuri; G L L Machado-Coelho; E Chiari; M T Bahia
Journal:  Parasitol Res       Date:  2005-06-07       Impact factor: 2.289

6.  Kinetoplast DNA signatures of Trypanosoma cruzi strains obtained directly from infected tissues.

Authors:  A R Vago; A M Macedo; R P Oliveira; L O Andrade; E Chiari; L M Galvão; D Reis; M E Pereira; A J Simpson; S Tostes; S D Pena
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

7.  Probing population dynamics of Trypanosoma cruzi during progression of the chronic phase in chagasic patients.

Authors:  Daniella Alchaar D'Avila; Andréa Mara Macedo; Helder Magno Silva Valadares; Eliane Dias Gontijo; Ana Maria de Castro; Carlos Renato Machado; Egler Chiari; Lúcia Maria Cunha Galvão
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

8.  Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes.

Authors:  Max Jean de Ornelas Toledo; Maria Terezinha Bahia; Cláudia M Carneiro; Olindo Assis Martins-Filho; Michel Tibayrenc; Christian Barnabé; Washington Luis Tafuri; Marta de Lana
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

9.  Sequence diversity and differential expression of Tc52 immuno-regulatory protein in Trypanosoma cruzi: potential implications in the biological variability of strains.

Authors:  Françoise Mathieu-Daudé; Marie-France Bosseno; Edwin Garzon; Joël Lelièvre; Denis Sereno; Ali Ouaissi; Simone Frédérique Brenière
Journal:  Parasitol Res       Date:  2007-07-23       Impact factor: 2.289

10.  Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.

Authors:  Jaquelline Carla Valamiel de Oliveira-Silva; Girley Francisco Machado-de-Assis; Maykon Tavares Oliveira; Nívia Carolina Noguieira Paiva; Márcio Sobreira Silva Araújo; Cláudia Martins Carneiro; Olindo Assis Martins-Filho; Helen Rodrigues Martins; Marta de Lana
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-01-23       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.